Aug 14 (Reuters)-
Enbio Holdings, Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2023 Jun 30, 2022 Mar 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 3.42 2.67 9.73
(+28.3 pct) (+38.9 pct) (+19.8 pct)
Operating 240 mln 715 mln 487 mln
(-66.4 pct) (+84.3 pct) (-64.1 pct)
Recurring 345 mln 810 mln 339 mln
(-57.4 pct) (+104.7 pct) (-74.8 pct)
Net 170 mln 480 mln 201 mln
(-64.4 pct) (+99.6 pct) (-75.2 pct)
EPS 22.79 yen 72.28 yen 26.83 yen
Ann Div 8.00 yen 8.00 yen
-Q2 div NIL NIL
-Q4 div 8.00 yen 8.00 yen
NOTE - Enbio Holdings, Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6092.T